StoneX Group’s iSpecimen ISPC Stock Holding History

StoneX Group’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-493	Closed	-$3.09K	–	1512
2026 Q1	$3.09K	Buy	+493	New	+$5.54K	﹤0.01%	896
2024 Q3	–	Sell	-18	Closed	-$4.55K	–	747
2024 Q2	$4.55K	Buy	+18	New	+$4.32K	﹤0.01%	624

Other funds holding ISPC

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

StoneX Group's ISPC Position: Q2 2026 in Review

StoneX Group sold out of iSpecimen (ISPC) in Q2 2026, closing a stake of 493 shares — an estimated $3.09K sold.

StoneX Group first reported a position in ISPC in Q2 2024 and held it in 2 quarters. The position peaked at $4.55K in Q2 2024. 8 funds tracked by Wall St. Rank hold ISPC as of Q2 2026.

StoneX Group reported no remaining iSpecimen position as of Q2 2026 after selling out during the quarter.
StoneX Group sold 493 iSpecimen shares in Q2 2026, an estimated $3.09K.
StoneX Group first reported a position in iSpecimen in Q2 2024 and held it in 2 quarters.
StoneX Group's iSpecimen position peaked at $4.55K in Q2 2024.
8 funds tracked by Wall St. Rank held iSpecimen as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.